{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T06:57:00Z","timestamp":1782975420904,"version":"3.54.5"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81660611"],"award-info":[{"award-number":["81660611"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81760746"],"award-info":[{"award-number":["81760746"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004001","name":"Guizhou Science and Technology Department","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010828","name":"Department of Education of Guizhou Province","doi-asserted-by":"publisher","award":["[2018]055"],"award-info":[{"award-number":["[2018]055"]}],"id":[{"id":"10.13039\/501100010828","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012465","name":"Zunyi Medical College","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012465","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.ejphar.2021.174558","type":"journal-article","created":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T06:36:24Z","timestamp":1633761384000},"page":"174558","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Magnesium demethylcantharidate inhibits hepatocellular carcinoma cell invasion and metastasis via activation transcription factor FOXO1"],"prefix":"10.1016","volume":"911","author":[{"given":"Fang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Ting","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-li","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Fei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8615-4710","authenticated-orcid":false,"given":"Yun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2021.174558_bib1","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.semcancer.2014.07.008","article-title":"FOXM1: a key oncofoetal transcription factor in health and disease","volume":"29","author":"Bella","year":"2014","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ejphar.2021.174558_bib2","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1111\/jcmm.12612","article-title":"Synergistic antitumour activity of RAF265 and ZSTK474 on human TT medullary thyroid cancer cells","volume":"19","author":"Bertazza","year":"2015","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.ejphar.2021.174558_bib3","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1158\/1078-0432.CCR-10-1891","article-title":"Pancreatic tumor suppression by benzyl isothiocyanate is associated with inhibition of PI3K\/AKT\/FOXO pathway","volume":"17","author":"Boreddy","year":"2011","journal-title":"Clin. Cancer Res. : Off. J. Am. Assoc. Canc. Res."},{"key":"10.1016\/j.ejphar.2021.174558_bib4","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1053\/j.gastro.2009.08.005","article-title":"SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis","volume":"137","author":"Calvisi","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2021.174558_bib5","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jhep.2018.09.022","article-title":"Ketoconazole exacerbates mitophagy to induce apoptosis by downregulating cyclooxygenase-2 in hepatocellular carcinoma","volume":"70","author":"Chen","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2021.174558_bib6","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/ijc.10479","article-title":"Effector mechanisms of norcantharidin-induced mitotic arrest and apoptosis in human hepatoma cells","volume":"100","author":"Chen","year":"2002","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejphar.2021.174558_bib7","doi-asserted-by":"crossref","first-page":"e2324","DOI":"10.1038\/cddis.2016.227","article-title":"Chemotherapy resistance and metastasis-promoting effects of thyroid hormone in hepatocarcinoma cells are mediated by suppression of FoxO1 and Bim pathway","volume":"7","author":"Chi","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejphar.2021.174558_bib8","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.18632\/oncotarget.13786","article-title":"FOXO1 inhibits the invasion and metastasis of hepatocellular carcinoma by reversing ZEB2-induced epithelial-mesenchymal transition","volume":"8","author":"Dong","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2021.174558_bib9","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJMra1001683","article-title":"Hepatocellular carcinoma","volume":"365","author":"El-Serag","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2021.174558_bib10","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.biopha.2013.04.014","article-title":"Upregulation of miR-370 contributes to the progression of gastric carcinoma via suppression of FOXO1","volume":"67","author":"Fan","year":"2013","journal-title":"Biomed. & Pharmacother. = Biomedecine & pharmacotherapie"},{"key":"10.1016\/j.ejphar.2021.174558_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080807","article-title":"The antiapoptotic function of miR-96 in prostate cancer by inhibition of FOXO1","volume":"8","author":"Fendler","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2021.174558_bib12","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejphar.2021.174558_bib13","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/ng1193-230","article-title":"Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma","volume":"5","author":"Galili","year":"1993","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejphar.2021.174558_bib14","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.3892\/mmr.2015.3538","article-title":"cDNA microarray analysis of the effect of cantharidin on DNA damage, cell cycle and apoptosis-associated gene expression in NCI-H460 human lung cancer cells in vitro","volume":"12","author":"Hsia","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ejphar.2021.174558_bib15","first-page":"838651","article-title":"Norcantharidin, derivative of cantharidin, for cancer stem cells","volume":"2013","author":"Hsieh","year":"2013","journal-title":"Evid. base Compl. Alternative Med. : eCAM"},{"key":"10.1016\/j.ejphar.2021.174558_bib16","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1038\/onc.2017.10","article-title":"CCDC178 promotes hepatocellular carcinoma metastasis through modulation of anoikis","volume":"36","author":"Hu","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.ejphar.2021.174558_bib17","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/j.jnutbio.2013.01.010","article-title":"Quercetin induces growth arrest through activation of FOXO1 transcription factor in EGFR-overexpressing oral cancer cells","volume":"24","author":"Huang","year":"2013","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.ejphar.2021.174558_bib18","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.biopha.2017.01.010","article-title":"Magnolin inhibits prostate cancer cell growth in vitro and in vivo","volume":"87","author":"Huang","year":"2017","journal-title":"Biomed. & Pharmacother. = Biomedecine & pharmacotherapie"},{"key":"10.1016\/j.ejphar.2021.174558_bib19","doi-asserted-by":"crossref","first-page":"6843","DOI":"10.2147\/OTT.S117743","article-title":"Synergistic activity of vorinostat combined with gefitinib but not with sorafenib in mutant KRAS human non-small cell lung cancers and hepatocarcinoma","volume":"9","author":"Jeannot","year":"2016","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.ejphar.2021.174558_bib20","doi-asserted-by":"crossref","first-page":"19146","DOI":"10.1074\/jbc.M117.793760","article-title":"NK3 homeobox 1 (NKX3.1) up-regulates forkhead box O1 expression in hepatocellular carcinoma and thereby suppresses tumor proliferation and invasion","volume":"292","author":"Jiang","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2021.174558_bib21","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s12011-017-1233-6","article-title":"Acute and cumulative effects of unmodified 50-nm nano-ZnO on mice","volume":"185","author":"Kong","year":"2018","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.ejphar.2021.174558_bib22","first-page":"795","article-title":"Cantharidin induces DNA damage and inhibits DNA repair-associated protein expressions in TSGH8301 human bladder cancer cell","volume":"35","author":"Kuo","year":"2015","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ejphar.2021.174558_bib23","doi-asserted-by":"crossref","first-page":"pe19","DOI":"10.1126\/scisignal.2001991","article-title":"Estrogen receptor beta: switching to a new partner and escaping from estrogen","volume":"4","author":"Leung","year":"2011","journal-title":"Sci. Signal."},{"key":"10.1016\/j.ejphar.2021.174558_bib24","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/tox.22273","article-title":"Anticancer effects of cantharidin in A431 human skin cancer (Epidermoid carcinoma) cells in vitro and in vivo","volume":"32","author":"Li","year":"2017","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.ejphar.2021.174558_bib25","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/hep.24479","article-title":"Hypoxia-inducible factor 1 alpha-activated angiopoietin-like protein 4 contributes to tumor metastasis via vascular cell adhesion molecule-1\/integrin beta1 signaling in human hepatocellular carcinoma","volume":"54","author":"Li","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2021.174558_bib26","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/j.1349-7006.2010.01523.x","article-title":"Cantharidin, a potent and selective PP2A inhibitor, induces an oxidative stress-independent growth inhibition of pancreatic cancer cells through G2\/M cell-cycle arrest and apoptosis","volume":"101","author":"Li","year":"2010","journal-title":"Cancer Sci."},{"key":"10.1016\/j.ejphar.2021.174558_bib27","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3892\/ijo.2016.3799","article-title":"Combination of metformin and sorafenib suppresses proliferation and induces autophagy of hepatocellular carcinoma via targeting the mTOR pathway","volume":"50","author":"Ling","year":"2017","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejphar.2021.174558_bib28","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2021.174558_bib29","article-title":"Overexpression of Nrf2 protects against microcystin-induced hepatotoxicity in mice","volume":"9","author":"Lu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2021.174558_bib30","doi-asserted-by":"crossref","first-page":"317","DOI":"10.32604\/biocell.2020.09313","article-title":"CircRNA ATF6 promotes ovarian cancer cell progression by activating PTEN\/mTOR signaling pathway","volume":"45","author":"Ma","year":"2021","journal-title":"Biocell"},{"key":"10.1016\/j.ejphar.2021.174558_bib31","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ejpb.2014.04.016","article-title":"Improved antitumor activity and reduced cardiotoxicity of epirubicin using hepatocyte-targeted nanoparticles combined with tocotrienols against hepatocellular carcinoma in mice","volume":"88","author":"Nasr","year":"2014","journal-title":"Eur. J. Pharm. Biopharm. : Off. J. Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik eV"},{"key":"10.1016\/j.ejphar.2021.174558_bib32","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ccell.2016.02.011","article-title":"HDAC and PI3K antagonists cooperate to inhibit growth of MYC-driven medulloblastoma","volume":"29","author":"Pei","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejphar.2021.174558_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201905233","article-title":"Nanoparticle conjugation of ginsenoside Rg3 inhibits hepatocellular carcinoma development and metastasis","volume":"16","author":"Ren","year":"2020","journal-title":"Small"},{"key":"10.1016\/j.ejphar.2021.174558_bib34","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.canep.2015.04.006","article-title":"Global and country underestimation of hepatocellular carcinoma (HCC) in 2012 and its implications","volume":"39","author":"Sartorius","year":"2015","journal-title":"Canc. Epidemiol."},{"key":"10.1016\/j.ejphar.2021.174558_bib35","doi-asserted-by":"crossref","first-page":"11836","DOI":"10.1038\/srep11836","article-title":"Cantharidin represses invasion of pancreatic cancer cells through accelerated degradation of MMP2 mRNA","volume":"5","author":"Shen","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2021.174558_bib36","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.semcancer.2017.09.009","article-title":"FOXO1: another avenue for treating digestive malignancy?","volume":"50","author":"Shi","year":"2018","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ejphar.2021.174558_bib37","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1158\/1535-7163.MCT-15-0976","article-title":"Single agent and synergistic activity of the \"First-in-Class\" dual PI3K\/BRD4 inhibitor SF1126 with sorafenib in hepatocellular carcinoma","volume":"15","author":"Singh","year":"2016","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.ejphar.2021.174558_bib38","doi-asserted-by":"crossref","first-page":"108939","DOI":"10.1016\/j.cbi.2020.108939","article-title":"Cantharidin suppresses gastric cancer cell migration\/invasion by inhibiting the PI3K\/Akt signaling pathway via CCAT1","volume":"317","author":"Song","year":"2020","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejphar.2021.174558_bib39","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1142\/S0192415X15500366","article-title":"Cantharidin induces apoptosis through the calcium\/PKC-regulated endoplasmic reticulum stress pathway in human bladder cancer cells","volume":"43","author":"Su","year":"2015","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.ejphar.2021.174558_bib40","doi-asserted-by":"crossref","first-page":"639","DOI":"10.32604\/biocell.2020.013053","article-title":"Oncolytic adenovirus targeting LASP-1 inhibited renal cell cancer progression","volume":"44","author":"Sun","year":"2020","journal-title":"Biocell"},{"key":"10.1016\/j.ejphar.2021.174558_bib41","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1200\/JCO.2010.28.7805","article-title":"Hepatocellular carcinoma: consensus recommendations of the national cancer institute clinical trials planning meeting","volume":"28","author":"Thomas","year":"2010","journal-title":"J. Clin. Oncol. : Off. J. Am. Soc. Clinic. Oncol."},{"key":"10.1016\/j.ejphar.2021.174558_bib42","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1200\/JCO.2005.03.196","article-title":"Hepatocellular carcinoma: the need for progress","volume":"23","author":"Thomas","year":"2005","journal-title":"J. Clin. Oncol. : Off. J. Am. Soc. Clinic. Oncol."},{"key":"10.1016\/j.ejphar.2021.174558_bib43","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.3892\/or.2015.3942","article-title":"Cantharidin inhibits cell proliferation and promotes apoptosis in tongue squamous cell carcinoma through suppression of miR-214 and regulation of p53 and Bcl-2\/Bax","volume":"33","author":"Tian","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ejphar.2021.174558_bib44","first-page":"87","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.ejphar.2021.174558_bib45","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/gutjnl-2014-308270","article-title":"BCL-3 expression promotes colorectal tumorigenesis through activation of AKT signalling","volume":"65","author":"Urban","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.ejphar.2021.174558_bib46","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nrgastro.2012.199","article-title":"Medical therapies for hepatocellular carcinoma: a critical view of the evidence","volume":"10","author":"Villanueva","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2021.174558_bib47","first-page":"155","article-title":"Antimetastatic effects of norcantharidin on hepatocellular carcinoma cells by up-regulating FAM46C expression","volume":"9","author":"Wan","year":"2017","journal-title":"Am. J. Tourism Res."},{"key":"10.1016\/j.ejphar.2021.174558_bib48","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0378-8741(89)90062-7","article-title":"Medical uses of mylabris in ancient China and recent studies","volume":"26","author":"Wang","year":"1989","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejphar.2021.174558_bib49","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3892\/or.2014.3266","article-title":"PP2A inhibitors suppress migration and growth of PANC-1 pancreatic cancer cells through inhibition on the Wnt\/beta-catenin pathway by phosphorylation and degradation of beta-catenin","volume":"32","author":"Wu","year":"2014","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ejphar.2021.174558_bib50","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1186\/s12935-020-01463-w","article-title":"The combination of Biochanin A and SB590885 potentiates the inhibition of tumour progression in hepatocellular carcinoma","volume":"20","author":"Xiao","year":"2020","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ejphar.2021.174558_bib51","first-page":"97","article-title":"Liver-directed treatment modalities for primary and secondary hepatic tumors","volume":"89","author":"Yamane","year":"2009","journal-title":"Surg. Clin."},{"key":"10.1016\/j.ejphar.2021.174558_bib52","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.3892\/or.2013.2957","article-title":"Post-transcriptional repression of FOXO1 by QKI results in low levels of FOXO1 expression in breast cancer cells","volume":"31","author":"Yu","year":"2014","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ejphar.2021.174558_bib53","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12935-016-0328-z","article-title":"miRNA-135a promotes hepatocellular carcinoma cell migration and invasion by targeting forkhead box O1","volume":"16","author":"Zeng","year":"2016","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ejphar.2021.174558_bib54","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.3892\/ol.2014.2611","article-title":"Cantharidin induces G2\/M phase arrest and apoptosis in human gastric cancer SGC-7901 and BGC-823 cells","volume":"8","author":"Zhang","year":"2014","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ejphar.2021.174558_bib55","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.18632\/oncotarget.6780","article-title":"GNA13 as a prognostic factor and mediator of gastric cancer progression","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2021.174558_bib56","doi-asserted-by":"crossref","first-page":"5044","DOI":"10.1021\/acs.chemmater.0c00797","article-title":"Microfluidic synthesis of multimode Au@CoFeB-Rg3 nanomedicines and their cytotoxicity and anti-tumor effects","volume":"32","author":"Zhang","year":"2020","journal-title":"Chem. Mater."},{"key":"10.1016\/j.ejphar.2021.174558_bib57","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1080\/03639045.2018.1449853","article-title":"Synthesis of nanomedicines by nanohybrids conjugating ginsenosides with auto-targeting and enhanced MRI contrast for liver cancer therapy","volume":"44","author":"Zhao","year":"2018","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejphar.2021.174558_bib58","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.canlet.2008.06.029","article-title":"Cantharidin reverses multidrug resistance of human hepatoma HepG2\/ADM cells via down-regulation of P-glycoprotein expression","volume":"272","author":"Zheng","year":"2008","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejphar.2021.174558_bib59","doi-asserted-by":"crossref","first-page":"104868","DOI":"10.1016\/j.phrs.2020.104868","article-title":"Cantharidin treatment inhibits hepatocellular carcinoma development by regulating the JAK2\/STAT3 and PI3K\/Akt pathways in an EphB4-dependent manner","volume":"158","author":"Zhu","year":"2020","journal-title":"Pharmacol. Res."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299921007147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299921007147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:13:55Z","timestamp":1762143235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299921007147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":59,"alternative-id":["S0014299921007147"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.174558","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Magnesium demethylcantharidate inhibits hepatocellular carcinoma cell invasion and metastasis via activation transcription factor FOXO1","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.174558","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"174558"}}